Chair in Translational Medicine - Institute for Interdisciplinary Innovation in healthcare (I³h)
The role of public-private partnerships in the provision of equitable access to medical care to the patients in low- and middle-income countries
The analysis of pharmaceutical business models including licensing, differential pricing, advanced market commitments and the literature on PRND-focused PPPs will be discussed with experts across the healthcare spectrum. The research results will be submitted as a peer-reviewed publication in an international, scientific journal. The information gathered during the empirical study will serve as a follow-on article of the PhD research during the post-doctoral mandate of the researcher and the scientific articles that formed the base to obtain the PhD. We will also reflect further upon the appropriate role of PPPs for public health. Finally, recommendations for the approach of the different policy makers in establishing a clearly defined role for different stakeholders in PRND-focused PPPs will be presented, so that community research, philanthropy, patient advocacy and new insights in IP frameworks will lead to improved access to therapies in PRND-endemic countries.
Patient Organizations in Biomedical Public-Private PartnershipsThe research results will be submitted as a peer-reviewed publication in an international, scientific journal. The information gathered during the empirical study will serve as a follow-on article of the PhD research during a Post-Doctoral Mandate (PhD defense planned in December 2014) and the scientific articles that formed the base to obtain the PhD. We will also reflect further upon the appropriate role of PPPs for public health. Finally, recommendations for the approach of the different policy makers in establishing a clearly defined role for Patient Organizations in PPPs will be presented, so that community research, patient participation and new insights in personalized medicines will lead to more innovative therapies.
Mapping of EU and US Precompetitive Public-Private Partnerships (PPPs)
Hilde Stevens, PhD, is senior researcher and lecturer at the I³h Institute (Université libre de Bruxelles, Belgium) and holds the Chair in Translational Medicine supported by the Fund Baillet Latour. Together with Prof. Michel Goldman, Academic Director of the I³h Institute, Hilde has set up the Interdisciplinary Program in Translational Medicine. This unique program is intended to provide the next generation of healthcare providers with an insight in the interdisciplinary skills needed to shape the future of medicine, to help them understand the respective roles of the different stakeholders in healthcare, and to offer unique opportunities to interact with experts and colleagues from a wide range of disciplines and environments. The program is directed to master students, PhD students, post-doctoral fellows and professionals having an interest in healthcare (www.i3health.eu).
Hilde focuses her research on patient-centricity, collaborative innovation models, intellectual property (IP) and mechanisms governing access to medicines in the least developed countries (LDCs). Hilde particularly focuses on the governance and performance of public-private partnerships and their added value in the acceleration of innovative therapy development. It is her aim to define sound and robust bases for interdisciplinary patient-focused approaches to move collaborative innovation forward. To this end, Hilde is Education Officer in ENP Belgium, the Belgian Patient Platform, supported by EUPATI (European Patients’ Academy on Therapeutic Innovation). As Education Officer, she coordinates education activities, guarantees the quality and accuracy of the educational material as well as the independence of the provided material and activities and builds partnerships with the various stakeholders, focusing on patient education.
She holds a Master Degree in Biomedical Science (Ghent University, Belgium), a Master Degree in General Management (Vlerick Business School, Belgium), a Master Degree in Intellectual Property Law (Brussels University, Belgium) and a PhD in Biomedical Sciences from the University of Leuven (Belgium). Hilde worked as a science consultant and was a patent engineer for several years.